Andrew VAILLANT

Chief Scientific Officer

Replicor Inc.

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Tissue Engineering Tissue Engineering professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrew Vaillant is the Chief Scientific Officer at Replicor Inc. in Canada. His research focuses on advancements in hepatitis B virus (HBV) treatment, including the evaluation of novel therapies and mechanisms for achieving functional cures. He has authored articles addressing HBV serum RNA kinetics, oligonucleotide-based therapies, and the evaluation of nucleic acid polymers.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (1)

Harel Dahari

Loyola University Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew VAILLANT

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Functional Cure for Hepatitis B Virus: Challenges and Achievements

HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cure

HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression

Bepirovirsen/GSK3389404: Antisense or TLR9 agonists?

Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects

Editorial: In vitro mechanistic evaluation of nucleic acid polymers: A cautionary tale

Letter to the Editor: Is the HBsAg response to RO7062931 an antisense effect?

Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy

Letter to the Editor: Examining HBV-RNA Kinetics During NA Treatment-Are NAs Multifunctional Antiviral Agents?

Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Collaborators (1)

Harel Dahari

Make your next move.